FDA Peptide Update: Category 2 Removals Explained 2026 predictions: historic FDA shift, plausible mechanisms, bespoke tx, RFK Jr., biotechs, state AGs, peptides, embryos The Niche The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian